These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 32639007)
1. Towards a roadmap to advance non-hormonal contraceptive multipurpose prevention technologies: strategic insights from key stakeholders†. Hemmerling A; Christopher E; Young Holt B Biol Reprod; 2020 Aug; 103(2):289-298. PubMed ID: 32639007 [TBL] [Abstract][Full Text] [Related]
2. A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV. Young Holt B; Dellplain L; Creinin MD; Peine KJ; Romano J; Hemmerling A Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):326-334. PubMed ID: 30247084 [TBL] [Abstract][Full Text] [Related]
3. Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel. Brady M; Manning J Antiviral Res; 2013 Dec; 100 Suppl():S25-31. PubMed ID: 24188700 [TBL] [Abstract][Full Text] [Related]
4. Prioritizing multipurpose prevention technology development and investments using a target product profile. Romano J; Manning J; Hemmerling A; McGrory E; Holt BY Antiviral Res; 2013 Dec; 100 Suppl():S32-8. PubMed ID: 24188707 [TBL] [Abstract][Full Text] [Related]
5. Emerging Technologies to Prevent Pregnancy and Sexually Transmitted Infections in Women. Seidman D; Hemmerling A; Smith-McCune K Semin Reprod Med; 2016 May; 34(3):159-67. PubMed ID: 26956691 [TBL] [Abstract][Full Text] [Related]
6. Canadian Contraception Consensus (Part 1 of 4). Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N; J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712 [TBL] [Abstract][Full Text] [Related]
7. Multipurpose prevention technologies for reproductive and sexual health. Stone A Reprod Health Matters; 2014 Nov; 22(44):213-7. PubMed ID: 25555778 [TBL] [Abstract][Full Text] [Related]
8. Vaginal multipurpose prevention technologies: promising approaches for enhancing women's sexual and reproductive health. Fernandes T; Baxi K; Sawarkar S; Sarmento B; das Neves J Expert Opin Drug Deliv; 2020 Mar; 17(3):379-393. PubMed ID: 32036727 [No Abstract] [Full Text] [Related]
10. Canadian Contraception Consensus (Part 2 of 4). Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725 [TBL] [Abstract][Full Text] [Related]
11. Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States. Hynes JS; Sales JM; Sheth AN; Lathrop E; Haddad LB Contraception; 2018 Mar; 97(3):277-284. PubMed ID: 29055782 [TBL] [Abstract][Full Text] [Related]
12. Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products. Schelar E; Polis CB; Essam T; Looker KJ; Bruni L; Chrisman CJ; Manning J Contraception; 2016 Jan; 93(1):32-43. PubMed ID: 26385588 [TBL] [Abstract][Full Text] [Related]
13. Strategic actions to advance multipurpose prevention technologies in low- and middle-income countries. Young Holt B; van der Straten A; Barker T; Chirenje ZM; Cameron AI; Scott C; Casas CP; Romano J Front Reprod Health; 2023; 5():1150857. PubMed ID: 37465533 [TBL] [Abstract][Full Text] [Related]
14. Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women. Hynes JS; Sheth AN; Lathrop E; Sales JM; Haddad LB J Womens Health (Larchmt); 2019 May; 28(5):665-672. PubMed ID: 30615569 [No Abstract] [Full Text] [Related]
15. Women Want Choices: Opinions from the Share.Learn.Shape Global Internet Survey About Multipurpose Prevention Technology (MPT) Products in Development. Friedland BA; Plagianos M; Savel C; Kallianes V; Martinez C; Begg L; Guthrie KM; Venkatasetty D; Pickett J; Haddad LB AIDS Behav; 2023 Jul; 27(7):2190-2204. PubMed ID: 36881183 [TBL] [Abstract][Full Text] [Related]
16. Optimizing the pipeline of multipurpose prevention technologies: opportunities across women's reproductive lifespans. Bershteyn A; Resar D; Kim HY; Platais I; Mullick S Front Reprod Health; 2023; 5():1169110. PubMed ID: 37325241 [TBL] [Abstract][Full Text] [Related]
17. Common ground: the opportunity of male contraceptives as MPTs. Vahdat HL; Nickels LM Front Reprod Health; 2023; 5():1278709. PubMed ID: 38023532 [TBL] [Abstract][Full Text] [Related]
18. Developing multipurpose reproductive health technologies: an integrated strategy. Harrison PF; Hemmerling A; Romano J; Whaley KJ; Young Holt B AIDS Res Treat; 2013; 2013():790154. PubMed ID: 23533733 [TBL] [Abstract][Full Text] [Related]
19. Contraceptive Method Use and Chlamydia Positivity Among California Family Planning Clients: The Case for New Multipurpose Prevention Technologies. Hunter LA; Nelson L; Chow JM; Holt BY; Bauer HM J Womens Health (Larchmt); 2018 Jun; 27(6):768-774. PubMed ID: 29377757 [TBL] [Abstract][Full Text] [Related]
20. Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention. Krovi SA; Johnson LM; Luecke E; Achilles SL; van der Straten A Adv Drug Deliv Rev; 2021 Sep; 176():113849. PubMed ID: 34186143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]